RE: Paraytec Covid-19 Test Versus Other Competitors Comparison4 May 2021 22:39
Continued
So, it seems Avacta’s test can only be useful in testing people with a high viral load! as per their RNS dated 20th April 2021 AND IT TAKES 20 MINUTES FOR ONE TEST!
extract: - Lateral flow rapid antigen tests are intended to provide a low cost means of identifying individuals with a high viral load that means they are more likely to infect others
Link below
https://avacta.com/lft-clinical-validation/
So as our Paraytec device can detect EXTREMELY LOW LEVELS OF Sars-Cov-2 virus particles!
Our test is far superior as it will detect people that are Asymptomatic but are still infectious!
In clinical validation studies, a total of 39 COVID-19 positive and 13 COVID-19 negative patient nasal swab samples have been used in a comparator PCR test to determine the viral load in each sample. Virus containing samples corresponding to the load distribution have been transferred to Paraytec's newly developed Viral Transport Medium to test the laboratory performance of Paraytec's photonics-based test. Using a maximum cycle threshold (Ct) value of 37, Paraytec's q-PCR testing regime has a sensitivity and specificity of 97.4% and 100% respectively. In the laboratory, the Paraytec test achieved 94% sensitivity and 100% specificity. Importantly, these results correspond to clinical samples with viral loads of approximately 100,000 virions per millilitre or less.
This outcome is important because it demonstrates the ability of the Paraytec test to identify people with relatively low viral loads - many of whom would be asymptomatic individuals or those with early-stage infection. The results demonstrate the potential performance advantage of the Paraytec test over lateral flow tests, which have only shown high levels of sensitivity in clinical samples with relatively high viral loads (typically, 500,000 virions per millilitre and higher).
https://www.londonstockexchange.com/news-article/BRH/further-update-re-paraytec-limited/14961092
DISCLAIMER
The text I have wrote here is my understanding of a comparison I have researched between the Paraytec Photonic Rapid 2-minute Covid-19 test (100% owned by Braveheart Investments Group) and the Avacta 20-minute Covid-19 test.
This information is based on facts I have read in published material from both the Paraytec (Braveheart) and Avacta’s Regulatory News Service Bulletins and should not be used to offer advice in either of the companies to invest in or not. Do your own research